As mentioned, a prospective study on a large group of patients (over 500 patients, Finnish smokers) on the role of serum ghrelin concentrations as a risk factor for the development of CRC was initiated by Murphy et al. [142] Low levels of this peptide 10 years before CRC diagnosis were significantly correlated with an increased risk of developing CC and RC. Here, GHRL is linked to colorectal carcinoma.